Principal Investigator(s): United States Department of Health and Human Services. National Center for Health Statistics
This data collection is the latest in a series of surveys that offers information on patients' visits to a national sample of office-based physicians. The National Ambulatory Medical Care Surveys collected information on all drugs/medications ordered, administered, or provided during the visits. The data items include the medication code, generic name and code, brand name, entry status, prescription status, federal controlled substance status, composition status, and related ingredient codes.
These data are available only to users at ICPSR member institutions. Because you are not logged in, we cannot verify that you will be able to download the data.
This study was originally provided by ICPSR. ICPSR provides leadership and training in data access, curation, and methods of analysis for a diverse and expanding social science research community.
U.S. Dept. of Health and Human Services, National Center for Health Statistics. NATIONAL AMBULATORY MEDICAL CARE SURVEY, 1985: DRUG MENTIONS. Washington, DC: U.S. Dept. of Health and Human Services, National Center for Health Statistics [producer], 1985. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 1989. doi:10.3886/ICPSR09096.v1
Persistent URL: http://doi.org/10.3886/ICPSR09096.v1
Scope of Study
Geographic Coverage: United States
Universe: Office visits to nonfederally employed physicians classified by the American Medical Association (AMA) or the American Osteopathic Association (AOA) as "office-based, patient care" (excluding specialties of anesthesiology, pathology, and radiology), from 84 Primary Sampling Units (PSUs) in the United States.
Data Types: survey data
Data Collection Notes:
The data contain ampersands (&), dashes (-), and blanks. The distribution of patient ages for each drug mention is: N=12,236 ages 65-74, N=8,307 ages 75-84, and N=1,706 ages 85 and over.
Sample: Stratified multistage probability design. In the first stage the PSUs were selected by a modified probability proportional-to-size procedure using separate sampling frames for SMSAs and for nonmetropolitan counties. The second stage consisted of a probability sample of practicing physicians selected from the master files maintained by the AMA and AOA. Within each PSU, all eligible physicians were stratified by 15 specialty groups. The final stage was the selection of patient visits within the annual practices of sample physicians. This involved two steps. First, the total physician sample was divided into 52 with each physician randomly assigned to one of the 52 weeks in the survey year. Second, a systematic random sample of visits was selected by the physician during the assigned week.
self-enumerated forms, DRUG PRODUCT INFORMATION FILE, and NATIONAL DRUG CODE DIRECTORY
Original ICPSR Release: 1989-09-26
Related Publications (?)
- Citations exports are provided above.
Export Study-level metadata (does not include variable-level metadata)